Modified Immune Cells (CD19 CAR T Cells) and Acalabrutinib for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
Clinical trial NCT04484012 · RECRUITING
Trial details
- NCT number
- NCT04484012
- Sponsor
- City of Hope Medical Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-31
- Primary completion
- 2026-09-02
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.